ATE99953T1 - Antivirales kombinationspraeparat. - Google Patents

Antivirales kombinationspraeparat.

Info

Publication number
ATE99953T1
ATE99953T1 AT89810100T AT89810100T ATE99953T1 AT E99953 T1 ATE99953 T1 AT E99953T1 AT 89810100 T AT89810100 T AT 89810100T AT 89810100 T AT89810100 T AT 89810100T AT E99953 T1 ATE99953 T1 AT E99953T1
Authority
AT
Austria
Prior art keywords
alpha
antiviral medication
combination antiviral
component
interferon
Prior art date
Application number
AT89810100T
Other languages
English (en)
Inventor
J David Prof Dr Gangemi
Heinz-Kurt Dr Hochkeppel
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Application granted granted Critical
Publication of ATE99953T1 publication Critical patent/ATE99953T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A61K38/212—IFN-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Virology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT89810100T 1988-02-13 1989-02-06 Antivirales kombinationspraeparat. ATE99953T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB888803365A GB8803365D0 (en) 1988-02-13 1988-02-13 Antiviral combination
EP89810100A EP0329609B1 (de) 1988-02-13 1989-02-06 Antivirales Kombinationspräparat

Publications (1)

Publication Number Publication Date
ATE99953T1 true ATE99953T1 (de) 1994-01-15

Family

ID=10631664

Family Applications (1)

Application Number Title Priority Date Filing Date
AT89810100T ATE99953T1 (de) 1988-02-13 1989-02-06 Antivirales kombinationspraeparat.

Country Status (15)

Country Link
US (1) US5137720A (de)
EP (1) EP0329609B1 (de)
JP (1) JP2781191B2 (de)
KR (1) KR0131077B1 (de)
AT (1) ATE99953T1 (de)
AU (1) AU623876B2 (de)
CA (1) CA1336578C (de)
DE (1) DE68912155T2 (de)
DK (1) DK62089A (de)
GB (1) GB8803365D0 (de)
IE (1) IE63493B1 (de)
IL (1) IL89248A (de)
NZ (1) NZ227944A (de)
PH (1) PH26919A (de)
ZA (1) ZA891053B (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW218846B (de) * 1992-04-07 1994-01-11 Ciba Geigy
FR2702659B1 (fr) * 1993-03-19 1995-08-25 Vacsyn Sa Compositions pour l'application en thérapeutique humaine, caractérisées par l'association d'un muramyl-peptide à une cytokine.
CA2157758A1 (en) * 1993-03-19 1994-09-29 Louis Chedid Compositions for use in human therapeutics, characterised by the association of a muramyl peptide with a cytokine
US5461512A (en) * 1993-11-30 1995-10-24 Eastman Kodak Company Zoom camera lens having three moving groups
DE69527405T2 (de) * 1994-10-19 2003-03-13 Novartis Ag, Basel Antivirale Ether von Aspartat-Protease-Substrat-Isosteren
US5786214A (en) * 1994-12-15 1998-07-28 Spinal Cord Society pH-sensitive immunoliposomes and method of gene delivery to the mammalian central nervous system
RU2140285C1 (ru) * 1999-01-25 1999-10-27 Гапонюк Петр Яковлевич Противовирусное средство - капли в нос "гриппферон"
DZ3332A1 (fr) 2000-03-31 2001-10-11 Purdue Research Foundation Methode de traitement a l'aide de conjugues ligand-immunogene
RU2187332C1 (ru) * 2000-12-18 2002-08-20 Гапонюк Петр Яковлевич Лечебное средство
RU2185840C1 (ru) * 2001-02-06 2002-07-27 Гапонюк Петр Яковлевич Лекарственный препарат для профилактики и лечения инфекционных заболеваний
DE60234782D1 (de) * 2001-09-28 2010-01-28 Purdue Research Foundation Behandlungsverfahren mit liganden-immunogenkonjugaten
US20030180348A1 (en) * 2002-03-22 2003-09-25 Levinson R. Saul Transcellular drug delivery system
WO2007092299A2 (en) * 2006-02-03 2007-08-16 Purdue Research Foundation Targeted conjugates and radiation
US7625555B2 (en) 2007-06-18 2009-12-01 Novagen Holding Corporation Recombinant human interferon-like proteins
US20080317836A1 (en) * 2007-06-19 2008-12-25 Discovery Partners Llc Topical compositions for anti-aging skin treatment
RU2488405C1 (ru) * 2012-07-17 2013-07-27 Илья Александрович Марков Лекарственное средство, обладающее противовирусным, противовоспалительным, иммуномодулирующим и обезболивающим действием, для местного и наружного применения - герпферон 2
KR101658048B1 (ko) 2014-06-25 2016-09-20 한국생명공학연구원 포스파티딜콜린 합성경로 관여 물질을 포함하는 항바이러스용 조성물

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS616000A (ja) * 1984-06-21 1986-01-11 木下　菊巳 回転色合せ盤
ATE78262T1 (de) * 1985-06-11 1992-08-15 Ciba Geigy Ag Hybrid-interferone.
US4774085A (en) * 1985-07-09 1988-09-27 501 Board of Regents, Univ. of Texas Pharmaceutical administration systems containing a mixture of immunomodulators
AU603820B2 (en) * 1986-08-13 1990-11-29 Takeda Chemical Industries Ltd. Antitumor agent

Also Published As

Publication number Publication date
DK62089A (da) 1989-08-14
KR890012670A (ko) 1989-09-18
IE63493B1 (en) 1995-05-03
JP2781191B2 (ja) 1998-07-30
AU2894389A (en) 1989-08-17
IL89248A0 (en) 1989-09-10
IL89248A (en) 1994-01-25
JPH021410A (ja) 1990-01-05
DE68912155T2 (de) 1994-06-16
KR0131077B1 (ko) 1998-04-17
US5137720A (en) 1992-08-11
EP0329609A2 (de) 1989-08-23
EP0329609A3 (en) 1990-05-16
AU623876B2 (en) 1992-05-28
IE890435L (en) 1989-08-13
PH26919A (en) 1992-12-03
CA1336578C (en) 1995-08-08
ZA891053B (en) 1989-10-25
DE68912155D1 (de) 1994-02-24
DK62089D0 (da) 1989-02-10
NZ227944A (en) 1991-08-27
EP0329609B1 (de) 1994-01-12
GB8803365D0 (en) 1988-03-16

Similar Documents

Publication Publication Date Title
AU586860B2 (en) Therapeutical application of phosphonylmethoxyalkyl adenines
DE68912155D1 (de) Antivirales Kombinationspräparat.
NO883896D0 (no) Konjugater av cytokiner med immunglobuliner.
DE3776946D1 (de) Nasale verabreichung von arzneimitteln.
DE3855099D1 (de) Nucleoside zur Verwendung für die Therapie
FI862011A0 (fi) Terapeutiska nukleosider.
PT911033E (pt) Utilizacao do interferao de consenso para a reducao dos efeitos secundarios do tratamento com interferoes na hepatite viral
DE3861494D1 (de) Pharmazeutische zusammensetzung zur behandlung von tumoren.
ES2037807T3 (es) Medicamentos que contienen en combinacion interferon y 1-desoxi-piperidinosas, procedimiento para su fabricacion y su aplicacion.
AU696629B2 (en) Use of bradykinin antagonists for the preparation of medicaments for the treatment of virus diseases

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
EELA Cancelled due to lapse of time